Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.12 | 0.02 |